Response to the Letter to the Editor: 1q Gain is a Frequent Finding in Preoperatively Treated Wilms Tumors, But of Limited Prognostic Value for Risk Satisfaction in the SIOP2009/Gesellschaft fur Padiatrische Onkologie und Hamatologie (GPOH) Trial

Pritchard-Jones Kathy; Williams Richard; Segers Heidi; van den Heuvel-Eibrink Marry; Pieters Rob; van Tinteren Harm; Vujanic Gordan; Bown Nick

首页> 外文期刊>Genes, Chromosomes and Cancer >Response to the Letter to the Editor: 1q Gain is a Frequent Finding in Preoperatively Treated Wilms Tumors, But of Limited Prognostic Value for Risk Satisfaction in the SIOP2009/Gesellschaft fur Padiatrische Onkologie und Hamatologie (GPOH) Trial

【24h】

Response to the Letter to the Editor: 1q Gain is a Frequent Finding in Preoperatively Treated Wilms Tumors, But of Limited Prognostic Value for Risk Satisfaction in the SIOP2009/Gesellschaft fur Padiatrische Onkologie und Hamatologie (GPOH) Trial

机译：回复给编辑的信：1q增益是术前治疗的维尔姆斯肿瘤的常见发现，但在SIOP2009 / Gesellschaft Fur Padiatrische Onkologie und Hamatologie（GPOH）试验中对风险满意的预后价值有限

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Genes, Chromosomes and Cancer》 |2015年第6期|共3页
作者
Pritchard-Jones Kathy; Williams Richard; Segers Heidi; van den Heuvel-Eibrink Marry; Pieters Rob; van Tinteren Harm; Vujanic Gordan; Bown Nick;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类医学遗传学;
关键词

相似文献

外文文献

1. Response to the Letter to the Editor: 1q Gain is a Frequent Finding in Preoperatively Treated Wilms Tumors, But of Limited Prognostic Value for Risk Satisfaction in the SIOP2009/Gesellschaft fur Padiatrische Onkologie und Hamatologie (GPOH) Trial [J] . Pritchard-Jones Kathy, Williams Richard, Segers Heidi, Genes, Chromosomes and Cancer . 2015,第6期

机译：回复给编辑的信：1q增益是术前治疗的维尔姆斯肿瘤的常见发现，但在SIOP2009 / Gesellschaft Fur Padiatrische Onkologie und Hamatologie（GPOH）试验中对风险满意的预后价值有限
2. Grusswort der Gesellschaft fur Padiatrische Onkologie und Hamatologie (GPOH) [J] . A. Eggert Klinische Paediatrie . 2013,第S1期

机译：儿科肿瘤与血液学学会（GPOH）的问候
3. Gain of 1q As a Prognostic Biomarker in Wilms Tumors (WTs) Treated With Preoperative Chemotherapy in the International Society of Paediatric Oncology (SIOP) WT 2001 Trial: A SIOP Renal Tumours Biology Consortium Study [J] . Chagtai Tasnim, Zill Christina, Dainese Linda, Journal of Clinical Oncology . 2016,第26期

机译：在国际儿科肿瘤学会（SIOP）WT 2001术前化学疗法治疗的Wilms肿瘤（WTs）中作为预后生物标记物获得1q的获利性试验：SIOP肾脏肿瘤生物学联合会研究
4. Gain of 1q As a Prognostic Biomarker in Wilms Tumors (WTs) Treated With Preoperative Chemotherapy in the International Society of Paediatric Oncology (SIOP) WT 2001 Trial: A SIOP Renal Tumours Biology Consortium Study [O] . Tasnim Chagtai, Christina Zill, Linda Dainese, -1

机译：在国际儿科肿瘤学会（SIOP）WT 2001术前化学疗法治疗的Wilms肿瘤（WTs）中作为预后生物标志物获得的1q增值试验：SIOP肾脏肿瘤生物学联合会研究
5. Gain of 1q As a Prognostic Biomarker in Wilms Tumors (WTs) Treated With Preoperative Chemotherapy in the International Society of Paediatric Oncology (SIOP) WT 2001 Trial: A SIOP Renal Tumours Biology Consortium Study [O] . Chagtai, Tasnim, Zill, Christina, Dainese, Linda, 2016

机译：在国际儿科肿瘤学会（SIOP）WT 2001术前化学疗法治疗的Wilms肿瘤（WTs）中作为预后生物标志物获得的1q增值试验：SIOP肾脏肿瘤生物学联合会研究

Response to the Letter to the Editor: 1q Gain is a Frequent Finding in Preoperatively Treated Wilms Tumors, But of Limited Prognostic Value for Risk Satisfaction in the SIOP2009/Gesellschaft fur Padiatrische Onkologie und Hamatologie (GPOH) Trial

著录项

相似文献

相关主题

期刊订阅